Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

NCT05790447 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumor
Refractory Tumor

Interventions

DRUG: Thymalfasin
RADIATION: Radiotherapy
DRUG: PD-1/PD-L1 inhibitor
DRUG: GM-CSF

Sponsor

Second Affiliated Hospital of Soochow University

Collaborators

[object Object]